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In peripheral lymphoid tissues, the number and 
repertoire diversity of T cells are maintained 
throughout life by a process called T cell ho-
meostasis (Stockinger et al., 2006; Surh et al., 
2006; Boyman et al., 2007). In mice, the ho-
meostatic maintenance of naive and memory 
CD4+ T cells and of naive CD8+ T cells has 
been shown to require both TCR signaling by 
the self-peptide–MHC and cytokines such as 
IL-7 (Goldrath and Bevan, 1999; Murali-Krishna 
et al., 1999; Tan et al., 2001; Ge et al., 2002; 
Surh and Sprent, 2002). The homeostasis of 
CD8+ memory T cells can be maintained by cy-
tokines such as IL-7, IL-15, and thymic stromal 
lymphopoietin  (TSLP;  Goldrath  and  Bevan, 
1999; Schluns et al., 2000; Tan et al., 2001; 
Ge et al., 2002; Surh and Sprent, 2002; Akamatsu 
et al., 2008). Previous studies have demonstrated 
that IL-7 can directly promote the survival and 
proliferation of activated human CD4+ T cells 
(Geginat et al., 2001; Rochman et al., 2007). 
Recently, a clinical study demonstrated that IL-7 
can induce the expansion of human CD4+ T cells 
in vivo (Sportès et al., 2008).
Although it is well established that IL-7 di-
rectly acts on CD4+ T cells, the relative impor-
tance of TSLP versus IL-7 in direct regulation of 
human CD4+ T cell activation and Th2 differen-
tiation  is  unclear.  We  have  previously  shown 
that TSLP can induce Th2 differentiation of na-
ive CD4+ T cells (Soumelis et al., 2002) or ro-
bust homeostatic expansion of naive and Th2 
memory CD4+ T cells indirectly via activating 
mDCs in humans (Watanabe et al., 2004; Ito   
et al., 2005; Wang et al., 2006). A recent study 
showed that human CD4+ T cells preactivated 
through TCR responded potently to TSLP and 
that this response could be further enhanced by 
IL-2 (Rochman et al., 2007). Studies using TSLP 
receptor (TSLPR)–deficient mice have clearly 
demonstrated that TSLPR expression by CD4+ 
T cells is essential for TSLP-mediated CD4+ T 
cell expansion and Th2 differentiation in vivo 
(Al-Shami et al., 2004; Zhou et al., 2005; He 
et al., 2008). The ability of mouse TSLP to di-
rectly act on CD4+ T cells was also demonstrated 
in vitro (Omori and Ziegler, 2007).
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Whether thymic stromal lymphopoietin (TSLP) directly induces potent human CD4+ T cell 
proliferation and Th2 differentiation is unknown. We report that resting and activated 
CD4+ T cells expressed high levels of IL-7 receptor a chain but very low levels of TSLP 
receptor (TSLPR) when compared with levels expressed in myeloid dendritic cells (mDCs). 
This was confirmed by immunohistology and flow cytometry analyses showing that only a 
subset of mDCs, with more activated phenotypes, expressed TSLPR in human tonsils in vivo. 
IL-7 induced strong STAT1, -3, and -5 activation and promoted the proliferation of naive 
CD4+ T cells in the presence of anti-CD3 and anti-CD28 monoclonal antibodies, whereas 
TSLP induced weak STAT5 activation, associated with marginally improved cell survival and 
proliferation, but failed to induce cell expansion and Th2 differentiation. The effect of 
TSLP on enhancing strong human T cell proliferation was observed only when sorted naive 
CD4+ T cells were cultured with mDCs at levels as low as 0.5%. TSLP could only induce 
naive CD4+ T cells to differentiate into Th2 cells in the presence of allogeneic mDCs. These 
results demonstrate that IL-7 and TSLP use different mechanisms to regulate human CD4+ 
T cell homeostasis.
©  2009  Lu  et  al.  This  article  is  distributed  under  the  terms  of  an  Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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mRNA. This is consistent with previous studies showing that 
IL-7 is dispensable for human B cell development and B cell–
mediated immune responses (Noguchi et al., 1993; Russell 
et al., 1995; Puel et al., 1998). Our current results confirm 
those of previous studies showing that mDCs and mast cells 
are the major cell types that express the TSLPR complex and 
respond to TSLP (Reche et al., 2001; Allakhverdi et al., 2007). 
In addition, pDCs can express the TSLPR complex upon 
CpG-A, -B, -C, Flu, or HSV activation (Fig. 1 A).
To further compare TSLPR expression in CD4+ T cells 
and mDCs at the protein level, we generated a panel of mAbs 
against the human TSLPR chain for use in flow cytometry. 
We found that resting naive CD4+ T cells expressed unde-
tectable levels of the TSLPR chain, whereas activated CD4+ 
T cells expressed very low levels of the TSLPR chain at days 
3, 4, 5, and 6 after anti-CD3 and anti-CD28 mAb activation, 
as shown by Rochman et al. (2007; Fig. 1 B). In contrast, 
naive CD4+ T cells expressed high levels of the IL-7Ra chain, 
which was further upregulated upon activation (Fig. 1 B). 
Moreover, freshly isolated mDCs expressed detectable levels 
of the TSLPR chain and IL-7Ra chain, and the expression 
levels of both were dramatically increased upon culture in 
medium alone or with IL-7, poly I:C, or TSLP (Fig. 1 C).
IL-7, but not TSLP, directly promotes strong naive CD4+  
T cell proliferation
To determine whether TSLP can directly promote the prolif-
eration of naive CD4+ T cells activated by anti-CD3 and anti-
CD28 mAbs, we first carefully titrated the concentration of 
anti-CD3 mAb to determine suboptimal and optimal doses that 
could be used to measure the effect of IL-7 or TSLP. Naive 
CD4+ T cells were purified by a cell sorter to a purity >99%, 
labeled with CFSE, and then cultured with immobilized anti-
CD3 and soluble anti-CD28 mAbs for 7 d. Cell proliferation 
was measured by FACS and counting the total number of cells. 
As shown in Fig. 2 (A and B), anti-CD3 mAb at 0.1 or 0.5 µg/ml 
was unable to induce T cell proliferation in the presence of   
1 µg/ml of anti-CD28 mAb. However, 1 µg/ml of anti-CD3 
mAb could induce significant proliferation of naive CD4+ T 
cells, and 2 µg/ml of anti-CD3 mAb could induce the maxi-
mum level of proliferation. We then choose the 0.5-µg/ml sub-
optimal dose of anti-CD3 mAb to test the effect of IL-7 and 
TSLP on promoting naive CD4+ T cell proliferation. We found 
that IL-7 at 0.5–62.5 ng/ml could strongly promote the prolif-
eration of naive CD4+ T cells activated with 0.5 µg/ml of anti-
CD3 and 1 µg/ml of anti-CD28 mAbs in a dose-dependent 
fashion, based on CFSE-labeling experiments (Fig. 2 C) and total 
viable cell counts (Fig. 2 D). However, TSLP at 1–625 ng/ml 
failed to promote the proliferation of naive CD4+ T cells under 
the  same  culture  condition  or  when  cultured  with  the   
2-µg/ml optimal dose of anti-CD3 mAb (Fig. 2, E and F). We 
occasionally observed that TSLP weakly promotes CD4+ T cell 
proliferation (Fig. 3 A), which was indicated by a small increase 
in the percentage of CFSE-labeled cells from 13.9 to 20.7%. In 
contrast, IL-7 increases the percentage of CFSE-labeled cells 
from 13.9 to 86.4% in the same experiment.
To determine whether the target cells of TSLP differ 
between humans and mice and whether TSLP and IL-7 have 
an equal potency in inducing human CD4+ T cell prolifera-
tion, expansion, and differentiation, we undertook four experi-
mental approaches. First, we performed a comprehensive 
analysis of the expression profile of TSLPR, IL-7Ra, and 
IL-2R common g (gc) chain transcripts in a variety of human 
immune cell types. Second, TSLPR chain protein expression 
was analyzed by flow cytometry using a newly generated 
monoclonal antibody. Third, we measured proliferation of 
highly purified human naive CD4+ T cells when cultured 
with  TSLP  in  the  presence  of  anti-CD3  and  anti-CD28 
mAbs, with or without the addition of myeloid DCs (mDCs) 
at 1:200 or 1:400 mDC/T cell ratios. And fourth, we ana-
lyzed the in vivo expression of TSLPR in human tonsils by 
immunohistology and flow cytometry. We report in this pa-
per that resting and activated CD4+ T cells expressed high 
levels of IL-7Ra but very low levels of TSLPR when com-
pared with levels expressed in mDCs, as was shown by 
Rochman et al. (2007). TSLPR expression on activated mDCs 
is at least 10× higher than that expressed by activated CD4+ 
T cells. In human tonsils, only a subset of mDCs was found 
to express TSLPR in vivo. We show that human IL-7 in-
duces much stronger T cell activation, survival, and prolifera-
tion than TSLP. TSLP induces strong T cell proliferation 
only in the presence of mDCs. These data suggest that IL-7 
and TSLP use different mechanisms to regulate CD4+ T cell 
homeostasis, which underscores differences in TSLP biology 
between mice and humans.
RESULTS AND DISCUSSION
Human mDCs and CD4+ T cells preferentially express TSLPR 
and IL-7R complexes, respectively
The TSLPR complex consists of the IL-7Ra chain and the 
TSLPR chain, which is a homologue of gc chain (Pandey et al., 
2000; Park et al., 2000; Reche et al., 2001). We performed a 
detailed microarray analysis of messenger RNA (mRNA) ex-
pression for the TSLPR, IL-7Ra, and gc chains in a variety 
of human immune cell types to assess their potential to re-
spond to TSLP or IL-7 (Fig. 1 A). The quality of this micro-
array data has been validated at the protein and functional 
levels by previous studies (Ito et al., 2005; Wang et al., 2006). 
We found that TSLPR chain mRNA was highly expressed by 
mDCs, especially after activation by anti-CD40 mAb, TSLP, 
or poly I:C. Activated plasmacytoid DCs (pDCs) and CD34+ 
human hematopoietic progenitor-derived mast cells were 
found to express low levels of TSLPR chain mRNA. TSLPR 
chain expression was undetectable in peripheral CD4+ naive, 
memory, and effector T cells, total CD8+ T cells, NK cells, 
and B cells. Interestingly, human naive CD4+ T cells expressed 
very low levels of TSLPR chain mRNA after anti-CD3 and 
anti-CD28 mAb activation, confirming a recent study by 
Rochman et al. (2007). The majority of human immune cell 
types expressed the IL-7Ra chain (Fig. 1 A). Unlike human 
T cells, which expressed high levels of the IL-7Ra chain, hu-
man B cells expressed undetectable levels of IL-7Ra chain JEM VOL. 206, September 28, 2009  2113
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TSLP mediates T cell homeostasis indirectly through mDCs
Our data demonstrate that human CD4+ T cells express very 
low levels of TSLPR upon activation with anti-CD3 and 
anti-CD28 mAbs, confirming a recent study (Rochman et al., 
Figure 1.  TSLPR complex expression on human immune cells. (A) Microarray profile of TSLPR and IL-7R complex mRNA expression in human  
immune cells is shown. Purification of cells and microarray analysis was conducted as previously described (Ito et al., 2005). Cells include the following: 
CD16+/ monocytes, CD4+CD11c+ mDCs, naive CD4+ T cells, central memory CD4+ T cells, effector memory CD4+ T cells, CD8+ T cells, CD123+BDCA2+pDCs, 
CD56+ NK cells, CD19+ B cells, CD34+ mast cells, basophils, and eosinophils. Nonstimulated and stimulated CD4+CD11c+ mDCs, pDCs, and naive CD4+ T 
cells were analyzed as well. The final expression output was normalized with the numerical value of one representing the estimated threshold of basal 
expression. Bars show the relative mRNA expression of the TSLPR, IL-7Ra, and IL-2Rg chains in each cell subtype. (B) FACS analysis of TSLPR complex 
expression in naive CD4+ T cells after indicated days of anti-CD3 and anti-CD28 mAb stimulation is shown. (C) FACS analysis of TSLPR complex expression 
in freshly isolated, unstimulated, or stimulated CD4+CD11c+ mDCs is shown. In B and C, numbers state the mean fluorescence intensity (MFI) of receptor 
minus isotype control. Filled histograms represent isotype control, and open histograms represent the staining of the receptor indicated at the left of 
each histogram. Stimulating conditions are shown at the top of each histogram. Data represents one of five experiments.
2007). However, we failed to observe that activated CD4+ T 
cells respond potently to TSLP (Rochman et al., 2007), which 
is in contrast to their robust response to IL-7 (Fig. 2 E). 
Because our previous studies have shown that mDCs activated 2114 DENDRITIC AND T CELL RESPONSE TO TSLP | Lu et al.
liferation in a dose-dependent fashion when they were cul-
tured with 0.25 or 0.5% mDCs in the presence of anti-CD3 
and anti-CD28 mAbs (Fig. 3 B).
TSLP does not directly induce human naive CD4+ T cells  
to differentiate into Th2 cells
A recent study in mice suggested that TSLP has the ability 
to induce naive CD4+ T cells to differentiate into Th2 cells 
(Omori and Ziegler, 2007). To determine whether TSLP can 
by TSLP potently induce the proliferation of CD4+ T cells at 
a DC/T cell ratio as low as 1:150 (Soumelis et al., 2002; 
Watanabe et al., 2004), we next investigated whether addition 
of a few mDCs could allow TSLP to promote T cell prolifera-
tion in the presence of anti-CD3 and anti-CD28 mAbs. We 
found that the presence of 0.25 and 0.5% of mDCs allowed 
TSLP to significantly enhance the proliferation of naive CD4+ 
T cells cultured with anti-CD3 and anti-CD28 mAbs (Fig. 3 A). 
We also found that TSLPs enhanced naive CD4+ T cell pro-
Figure 2.  IL-7, and not TSLP, has an additive effect on naive CD4+ T cell proliferation triggered by anti-CD3 and anti-CD28 mAbs. CFSE-
labeled purified naive CD4+ T cells were cultured for 7 d in the presence of anti-CD28 and anti-CD3 mAbs alone or with either IL-7 or TSLP. The doses of 
anti-CD28, anti-CD3, IL-7, and TSLP are indicated. T cell proliferation was measured by FACS analysis on day 4 and by cell count on day 7 of culture. For 
the FACS results, numbers in each square state the percentage of proliferated T cells. For the cell count, data points represent the total number of ex-
panded T cells of a donor, each represented by a different symbol. (A and B) The effect of increasing doses of anti-CD3 mAb on naive CD4+ T cell prolifera-
tion is shown. Data represent one of three independent experiments (A) and three donors (B). (C and D) The effect of increasing doses of IL-7 on naive 
CD4+ T cell proliferation in the presence of anti-CD28 and the suboptimal dose of anti-CD3 mAbs is shown. Data represent one of five independent ex-
periments (C) and five donors (D). (E and F) The effect of increasing doses of TSLP on naive CD4+ T cell proliferation in the presence of anti-CD28 mAb and 
either the suboptimal or optimal dose of anti-CD3 mAb is shown. Data represent one of five independent experiments (E) and five donors (F).JEM VOL. 206, September 28, 2009  2115
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cultured for 7 d with either pretriggered autologous mDCs at 
a 1:2 mDC/T cell ratio or pretriggered allogenic mDCs at a 
1:5 mDC/T cell ratio. Both autologous and allogenic mDCs 
had been triggered with TSLP or medium for 24 h before 
coculturing with the T cells (Fig. S1, C and D). After culture, 
T cells were reactivated with anti-CD3 and anti-CD28 mAbs 
for 24 h, and the culture medium was collected to measure 
directly induce human naive CD4+ T cells to differentiate into 
Th2 cells, purified naive CD4+ T cells were mixed with either 
fresh autologous mDCs at a 1:200 mDC/T cell ratio or with 
no mDCs and then cultured with anti-CD3 and anti-CD28 
mAbs only or in the presence of TSLP, IL-7, anti–IFN-g 
mAb and IL-4, or IFN-g and anti–IL-4 mAb for 7 d (Fig. S1, 
A and B). Meanwhile, purified naive CD4+ T cells were co-
Figure 3.  TSLP stimulates naive CD4+ T cell proliferation through mDCs. CFSE-labeled purified naive CD4+ T cells with or without autologous 
mDCs were cultured for 7 d with anti-CD3 and anti-CD28 mAbs alone or in the presence of TSLP, IL-7, or TSLP plus IL-7. The levels of mDCs and the doses 
of anti-CD28, anti-CD3, IL-7, and TSLP are indicated. Proliferation of T cells was detected by FACS on day 4 of culture; the percentage of proliferated  
T cells is indicated in each square. (A) The effect of IL-7 or TSLP on naive CD4+ T cell proliferation with or without autologous mDCs is shown. Data repre-
sent one of five independent experiments. (B) The effect of increasing doses of TSLP on naive CD4+ T cell proliferation with or without autologous mDCs is 
shown. Data represent one of five independent experiments.2116 DENDRITIC AND T CELL RESPONSE TO TSLP | Lu et al.
Figure 4.  TSLP activates weak STAT1 and STAT5 phosphorylation and maintains activated CD4+ T cell viability. (A) Naive CD4+ T cells, preacti-
vated with anti-CD3 and anti-CD28 mAbs, were restimulated with medium alone or with IL-7, TSLP, or TSLP plus IL-7 for 8 d. Every 2 d during culture, 
cells were stained with FITC–annexin V and PI and then analyzed by FACS. Numbers in the bottom right and left quarters state the percentage of apop-
totic and viable cells, respectively. Numbers in the top right quarters state the percentage of dead cells. Data represent one of five independent experi-
ments. (B) Survival curve based on the percentage of viable cells from experiments described in A. Data represents one of five independent experiments. 
(C) Naive CD4+ T cells, preactivated with anti-CD3 and anti-CD28 mAbs, were restimulated with medium alone (M) or with IL-2, IL-4, IL-7, TSLP, or TSLP 
with an isotype control mAb or neutralizing mAbs against IL-4 or TSLP. Activated STAT family molecules were detected by Western blotting with -actin 
serving as an internal control. The molecular mass (M.M.) of each protein is shown parenthetically. Data represent one of four experiments.JEM VOL. 206, September 28, 2009  2117
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Figure 5.  TSLPR expression in human tonsils. (A) FACS analysis of TSLPR, CD40, CD80, CD86, and HLA-DR expression in freshly isolated CD4+CD11c+ 
mDCs in tonsils is shown. (B) FACS analysis of TSLPR expression in freshly isolated CD4+, CD8+, or CD4+CD8+ T cells in tonsils is shown. (C) Identification 
of TSLPR-positive cell population in human tonsil tissue by immunohistology is shown. In A, numbers in each histogram state the MFI of receptor minus 
isotype control. Filled histograms represent isotype control, and open histograms represent the staining of the molecules indicated at the top of each 
histogram. In B, numbers in each square represents the percentage of cell subsets expressing indicated surface markers. Data represent one of five experi-
ments. In C (i), red cells represent TSLPR-positive population in tonsils. In C (ii), green cells represent tonsil CD20+ B cells; in C (iii), TSLPR-positive cells 
(red) localize at paracortical zone between the lymphoid follicles (green); in C (iv) among CD11c+ mDCs (green) and TSLPR-positive cells (red), there is a 
certain population expressing both CD11c and TSLPR (yellow); (i,ii,iii, and iv) magnification, X400. Bars, 50.0 µm.
levels of secreted cytokines by ELISA. We found that TSLP 
was unable to prime naive CD4+ T cells or T cells mixed with 
autologous mDCs at a 1:200 mDC/T cell ratio to secrete Th2 
cytokines in the presence of anti-CD3 and anti-CD28 mAbs 
(Fig. S1, A and B). In addition, TSLP could not induce naive 
CD4+ T cells to differentiate into Th2 cells when they were 
cocultured with pretriggered autologous mDCs at a 1:2 mDC/
T cell ratio (Fig. S1 C). This is consistent with the results of 
our previous study in which TSLP-activated autologous 
mDCs induced only homeostatic proliferation of naive CD4+ 
T cells and not Th2 differentiation (Watanabe et al., 2004; 
Wang et al., 2006). TSLP only induced strong Th2 differen-
tiation of the cultured naive CD4+ T cells in the presence 
of pretriggered allogeneic mDCs at a 1:5 mDC/T cell ratio 
(Fig. S1 D), confirming the results of our previous studies 
(Watanabe et al., 2004; Wang et al., 2006).
TSLP induced weak STAT1 and STAT5 activation  
and improved cell survival of naive CD4+ T cells
Because anti-CD3 and anti-CD28 mAbs can induce low levels of 
TSLPR expression in naive CD4+ T cells, we further examined 
whether TSLP could induce the signal transduced by the TSLPR 
complex. Naive CD4+ T cells were activated by anti-CD3 and 
anti-CD28 mAbs for 4 d and then cultured with medium alone, 
with IL-2, IL-4, IL-7, TSLP alone, or in the presence of an iso-
type control or neutralizing mAbs against IL-4 or TSLP. Activa-
tion of STAT family molecules in the T cells after 20 min of 
culture was examined by Western blot analysis. We found that all 
of  the  cytokines  investigated,  IL-2,  IL-4,  and  IL-7,  induced 
strong phosphorylation of multiple STAT proteins (Fig. 4 C). In 
contrast, TSLP only induced a very weak phosphorylation of 
STAT1 and STAT5, which was blocked by the TSLP-neutraliz-
ing mAb but not by the IL-4–neutralizing mAb or the isotype 
control, which confirms a recent study (Rochman et al., 2007).
Because STAT5 activation in T cells has been linked with 
improved cell survival that is uncoupled with cell proliferation 
(Isaksen et al., 2002), we further examined whether TSLP could 
improve the survival of naive CD4+ T cells activated by anti-
CD3 and anti-CD28 mAbs. Naive CD4+ T cells were cultured 
with anti-CD3 and anti-CD28 mAbs for 4 d. Cells were washed 
and then cultured for 8 d with medium alone or with IL-7, 
TSLP, or TSLP and IL-7 (Fig. 4, A and B). Viable and apoptotic 
cells were analyzed by propidium iodide (PI) and annexin V 
staining at different time points of culture (Fig. 4 A). We found 
that IL-7 could greatly maintain the survival of activated CD4+ 
T cells for up to 8 d, whereas TSLP could only marginally im-
prove the survival of activated CD4+ T cells (Fig. 4, A and B).
A subset of mDC with a more activated phenotype expresses 
TSLPR in human tonsils in vivo
To determine TSLPR-expressing cell types in vivo, we per-
formed flow cytometry and immunohistology analyses of 2118 DENDRITIC AND T CELL RESPONSE TO TSLP | Lu et al.
then cultured with anti-CD3 and anti-CD28 mAbs alone or with 0.5 ng/ml 
IL-7, 5–125 ng/ml TSLP, or 0.5 ng/ml IL-7 and 5–125 ng/ml TSLP. T cell 
proliferation was measured using a FACSCalibur (BD) and by cell count.
TSLPR complex expression in mDCs and T cells. Freshly isolated (Fig. 1) 
or stimulated naive CD4+ T cells and untreated or stimulated mDCs were 
stained with biotin-labeled anti-TSLPR antibody (2D10; Rochman et al., 
2007) or PE–anti–IL-7Ra antibody (Beckman Coulter). Cells were washed, 
stained with APC-streptavidin, and then analyzed with a FACSCalibur.
Th2 cytokine production analyses. Purified naive CD4+ T cells or T cells 
mixed with autologous mDCs at a 1:200 mDC/T cell ratio were cultured 
with anti-CD3 and anti-CD28 mAbs alone or with TSLP, IL-7, TSLP plus 
IL-7, anti-IL-4 plus IFN-g, and anti–IFN-g plus IL-4 conditions (Fig. S1). 
Meanwhile, T cells were cocultured with either autologous or allogenic 
mDCs, both pretriggered with either TSLP or medium for 7 d (Watanabe 
et al., 2004). After culturing, the T cells were restimulated with anti-CD3 and 
anti-CD28 mAbs for 24 h. Medium was collected and used to measure IL-4, 
IL-5, IL-13, and IFN-g levels by ELISA (all kits from R&D Systems).
Annexin V analyses. Naive CD4+ T cells were TCR triggered for 4 d. 
Cells were recultured in medium alone or with TSLP, IL-7, or TSLP and 
IL-7 for 8 d. Every 2 d, the preactivated T cells were stained with FITC– 
annexin V and PI (BD) and then analyzed with a FACSCalibur.
Western blot analysis. Naive CD4+ T cells were cultured with anti-CD3 and 
anti-CD28 mAbs for 4 d and then stimulated with medium alone or with IL-2, 
IL-4, IL-7, TSLP alone, or in the presence of isotype control or neutralizing 
mAb against IL-4 or TSLP for 20 min. The activation of STAT1, STAT3, 
STAT5, and STAT6 was detected by Western blotting using antibodies against 
the tyrosine-phosphorylated forms of STAT1, STAT3, STAT5, and STAT6 
(Cell Signaling Technology). Antibodies against STAT6 (Santa Cruz Biotech-
nology, Inc.) and -actin (Sigma-Aldrich) were used in the analysis as well.
Immunohistology. 6-µm frozen sections of human tonsil were fixed with 
cold acetone for 10 min and then incubated with mouse anti–human TSLPR 
mAb (3G11; our laboratory) at room temperature for 1 h in PBS. The slides 
were washed with PBS three times and incubated with red fluorescent-
labeled secondary antibody (Invitrogen) for 30 min. This was followed by 
anti-CD20 or anti-CD11c mAbs (BD) staining, and green fluorescent-
labeled secondary antibody (Invitrogen) was applied.
Online supplemental material. Fig. S1 demonstrates that TSLP cannot 
directly stimulate naive CD4+ T cells to produce Th2 cytokines. Online 
supplemental  material  is  available  at  http://www.jem.org/cgi/content/ 
full/jem.20090153/DC1.
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CD4+ T cells activated by anti-CD3 and anti-CD28 mAbs. 
TSLPR signaling in activated human naive CD4+ T cells led 
to only very weak activation of STAT1 and STAT5, as was 
recently demonstrated by Rochman et al. (2007), and mar-
ginally improved cell survival. In contrast, signaling from the 
IL-7R complex in activated naive CD4+ T cells led to robust 
activation of STAT1, STAT3, and STAT5, strong T cell 
proliferation, and prolonged T cell survival.
Both in vitro and in vivo data of our present study shows 
that human mDCs express very high levels of the TSLPR com-
plex. TSLPR expression levels correlate with the function of 
TSLP. We have previously demonstrated that TSLP-primed 
DCs can induce the robust expansion of naive CD4+ T cells in 
both allogenic and autologous systems. In the present study, we 
found that even at the very low mDC/T cell ratio of 1:200 
TSLP could strongly promote the proliferation of naive CD4+ T 
cells in culture with anti-CD3 and anti-CD28 mAbs. These re-
sults indicate that human IL-7 and TSLP use two different but 
complementary mechanisms to regulate peripheral T cell ho-
meostasis. IL-7 has a potent and direct effect on T cell activation 
and displays a limited effect on mDCs, and TSLP predominantly 
acts on mDCs and has a moderate effect directly on T cells.
MATERIALS AND METHODS
Microarray analysis. Microarray analysis was performed as described pre-
viously (Ito et al., 2005).
mDC isolation and culture. The institutional review board for human re-
search at The University of Texas M.D. Anderson Cancer Center (Houston, 
TX) approved this study. A FACSAria (BD) was used to purify (>99%) 
CD4+CD11c+lineage mDCs from buffy coats (Gulf Coast Regional Blood 
Center, Houston, TX) or human tonsils (Texas Children’s Hospital, Hous-
ton, TX). The mDCs were cultured in RPMI medium (Invitrogen) contain-
ing 2% human AB serum, alone or with 15 ng/ml TSLP (Ito et al., 2005),   
10 µg/ml poly I:C (InvivoGen), or 10 ng/ml IL-7 (R&D Systems) for 24 h.
Naive T cell isolation, culture, and proliferation assays. CD4+ 
CD45RA+CD45RO naive T cells were isolated as described previously 
(Wang et al., 2006). In some assays, the purified naive CD4+ T cells were cul-
tured in RPMI medium containing 4% human AB serum for 7 d in the pres-
ence  of  2.0  µg/ml  of  immobilized  anti-CD3  and  1.0  µg/ml  of  soluble 
anti-CD28 mAbs (BD) unless stated otherwise. CFSE-labeled naive CD4+ T 
cells were cultured with anti-CD28 and 0.1–5.0 µg/ml of anti-CD3 mAbs 
alone or with either 0.1–62.5 ng/ml IL-7 or 1–625 ng/ml TSLP. CFSE-
labeled naive CD4+ T cells were mixed with autologous CD4+CD11c+ mDCs 
at either a 1:200 or 1:400 mDC/T cell ratio or mixed without mDCs, and JEM VOL. 206, September 28, 2009  2119
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